Acetic Acid

Acetic Acid

SCHEMBL4274097

CC(=O)O.CC(=O)O.CC(=O)O.[KH]

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 2/20 0.88
LCK P06239 1/20 0.88
FYN P06241 1/20 0.88
LMNA P02545 3/20 0.56
TSHR P16473 2/20 0.50
THPO P40225 1/20 0.50
CA1 P00915 3/20 0.46
ALOX15 P16050 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
CA2 P00918 2/20 0.44
CA9 Q16790 1/20 0.44
ALDH1A1 P00352 5/20 0.39
TDP1 Q9NUW8 1/20 0.39
KDM4E B2RXH2 1/20 0.39
PTGS1 P23219 1/20 0.39
MMP12 P39900 1/20 0.39
CA4 P22748 1/20 0.39
SLC15A2 Q16348 1/20 0.38
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL9118003 1.00
Acetic Acid SCHEMBL15348726 1.00 FFAR3 (0.88) FFAR3LCKFYNLMNATSHR
Acetic Acid SCHEMBL4655827 1.00 FFAR3 (0.88) FFAR3LCKFYNLMNATSHR
Acetic Acid SCHEMBL9120240 1.00
Acetic Acid SCHEMBL49684 1.00
Acetic Acid SCHEMBL8382903 1.00 FFAR3 (0.88) FFAR3LCKFYNLMNATSHR
Acetic Acid SCHEMBL5578924 1.00 FFAR3 (0.88) FFAR3LCKFYNLMNATSHR
Acetic Acid SCHEMBL9118178 1.00 FFAR3 (0.88) FFAR3LCKFYNLMNATSHR
Acetic Acid SCHEMBL6383246 1.00 FFAR3 (0.88) FFAR3LCKFYNLMNATSHR
Acetic Acid SCHEMBL3447882 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118703598-A Label-free fluorescence detection system for detecting cleavage-connection activity of topoisomerase I and application thereof 青岛科技大学 2024-09-27 CN claimed
CN-118703598-A Label-free fluorescence detection system for detecting cleavage-connection activity of topoisomerase I and application thereof 青岛科技大学 2024-09-27 CN disclosed
CN-113816845-B Process for preparing trifluoroacetic acid 常熟三爱富中昊化工新材料有限公司 2024-04-16 CN disclosed
CN-111032648-B Organic triazine-containing molecules, in particular for optoelectronic devices 三星显示有限公司 2023-06-27 CN disclosed
CN-216440607-U Reaction system for producing solid-liquid chemical reaction 常熟三爱富中昊化工新材料有限公司 2022-05-06 CN disclosed
CN-113816845-A Preparation method of trifluoroacetic acid 常熟三爱富中昊化工新材料有限公司 2021-12-21 CN disclosed
CN-107849449-B Substituted benzotriazole phenolates and antioxidant compositions formed therefrom 3M创新有限公司 2020-12-29 CN disclosed
CN-111032648-A Organic triazine-containing molecules, in particular for optoelectronic devices 辛诺拉有限公司 2020-04-17 CN disclosed
US-20120220962-A1 TRANSDERMAL AND TOPICAL ADMINISTRATION OF VITAMINS USING BASIC PERMEATION ENHANCERS TECHNOLOGY RECOVERY SYSTEMS, LLC (US) 2012-08-30 US disclosed
US-20090317453-A1 TRANSDERMAL AND TOPICAL ADMINISTRATION OF DRUGS USING BASIC PERMEATION ENHANCERS DERMATRENDS, INC. (US) 2009-12-24 US disclosed
US-20090197849-A1 TRANSDERMAL AND TOPICAL ADMINISTRATION OF DRUGS USING BASIC PERMEATION ENHANCERS DERMATRENDS, INC. 2009-08-06 US disclosed
US-20070098747-A1 Topical pharmaceutical composition for the treatment of inflammatory dermatoses DERMATRENDS, INC. 2007-05-03 US disclosed
US-7205003-B2 Method and topical formulation for treating skin conditions associated with aging DERMATRENDS, INC. (US) 2007-04-17 US disclosed
US-20060002874-A1 Topical pharmaceutical composition to treat hyperpigmentation of the skin DERMATRENDS, INC. 2006-01-05 US disclosed
US-6943197-B2 Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses TECHNOLOGY RECOVERY SYSTEMS, LLC 2005-09-13 US disclosed
US-20050074487-A1 Transdermal and topical administration of drugs using basic permeation enhancers DERMATRENDS, INC. 2005-04-07 US disclosed
US-6846837-B2 Topical administration of basic antifungal compositions to treat fungal infections of the nails TECHNOLOGY RECOVERY SYSTEMS, LLC 2005-01-25 US disclosed
US-6821523-B2 APPLYING BASIC DRUGS TO SKINS FOR PROPHYLAXIS OF HUMAN PAPILLOMAVIRUS INFECTIONS; SKIN DISODERS DERMATRENDS, INC. 2004-11-23 US disclosed
US-6673363-B2 Transdermal and topical administration of local anesthetic agents using basic enhancers DERMATRENDS, INC. 2004-01-06 US disclosed
WO-2004000249-A1 TOPICAL PHARMACEUTICAL COMPOSITION TO TREAT HYPERPIGMENTATION OF THE SKIN DERMATRENDS, INC. (US) 2003-12-31 WO disclosed